Here are five reasons to feel hopeful as we close out the year:
1. GLA funded six new research grants for ground-breaking work
Donating to GLA means funding research with the potential to change patient lives, but where specifically does that funding go?
GLA’s 2026 research portfolio targets critical unmet needs in understanding the impact of Lyme disease on children, improving early diagnosis, uncovering the biological mechanisms underlying persistent symptoms, and advancing innovative treatments. Through six newly funded projects, GLA is supporting investigators working to address these challenges and move the field forward.
To learn more about this year's projects and the researchers leading them, see Global Lyme Alliance Announces Six New Research Grants To Transform the Future of Lyme Disease Diagnosis and Treatment.
We all want better diagnostics and treatment so that people don’t suffer long-term from Lyme and other tick-borne illnesses, but many of us are unfortunately already in that boat. We need targeted research on different factors that led to our persistent symptoms and, most of all, we want relief from long-term suffering.
This is why research into the underlying causes of persistent symptoms is so important. GLA grantees Drs. Isaac Chiu and Jun Huh of Harvard Medical School are investigating how Lyme bacteria may trigger lasting nerve damage and chronic pain through interactions between the immune and nervous systems. As part of this effort, they are developing a mouse model to determine whether long-term symptoms can be studied in the laboratory, which would address a longstanding gap in Lyme disease research.
By better understanding the biological mechanisms that may contribute to persistent symptoms, this research could open doors to new treatment targets, and ultimately inform the development of more effective treatments.
GLA doesn’t just support those already impacted by Lyme; it also helps spread Lyme awareness, so others know how to prevent tick bites and protect themselves against Lyme disease, which is estimated to affect almost half a million people in the U.S. each year. GLA Ambassadors are on the front lines of this work, teaching tick prevention, collaborating with other organizations, and fundraising. Over 150 volunteers schedule presentations, meet with local organizations and civic groups, and complete grassroots fundraisers.
When I spoke with GLA’s Education and Grant Program Manager Kristen Harris, who oversees the Ambassador Program, I learned that GLA Ambassadors can help their communities in big and small ways, even if they are bedridden or housebound. As a GLA Ambassador and the Chair of Next Gen, Christina Kovacs says, “I’ve learned that no action is too small. Everything we do as Ambassadors to spread awareness, no matter the scale, creates a ripple effect in the world.”
To learn more, see Empowering Lyme Disease Awareness: Join the GLA Ambassador Program.
This Fall, Global Lyme Alliance Ambassadors Marissa Tavella and Arianna Cavallino hosted The Drive to End Lyme, a Topgolf fundraising event. Held in Holtsville, NY, the event brought the community together for a fun day of golf, raffles, and food, all while raising awareness—and an incredible $15,000 for Lyme disease research! This truly demonstrates the power of volunteer leadership and community engagement in advancing GLA’s mission.
Awareness efforts by organizations like GLA are getting the attention of lawmakers, who are recognizing just how big of a problem Lyme disease is and how much support is needed for it. This fall, the Kay Hagan Tick Act was reauthorized, which reauthorizes Regional Centers of Excellence in Vector-Borne Diseases for five years; reauthorizes CDC grants to state health departments to strengthen their capacity for surveillance, prevention, and response to vector-borne diseases; and continues implementing and updating the U.S. Department of Health and Human Services (HHS) National Public Health Strategy to Prevent and Control Vector-Borne Disease in People. To learn more, see Kay Hagan Tick Act Reauthorized: What it Means for Lyme Disease and New Federal Lyme Disease Legislation: Explained.
That’s not all. The HHS also outlined new Lyme disease initiatives, including a multi-million-dollar national tick control pilot program, expanded LymeX innovation activities, and new research initiatives related to alpha-gal syndrome. The HHS also aims to reduce Lyme disease cases by 25% by 2035, compared to 2022 levels.
With continued support of GLA’s work, we’re aiming to reduce that number even more. This year’s accomplishments give me reason to hope!
***